Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Grant to support phase II development of AKL's APPA for osteoarthritis

Feb. 18, 2019

Nimbus Lakshmi discloses new TYK2 inhibitors

Feb. 14, 2019

Misplaced energy turns T cells proinflammatory

Feb. 7, 2019

Evidence of molecular mechanism of DZ-2002 on glomerulonephritis in SLE

Feb. 5, 2019

TNF levels do not predict TNF blocker success

Feb. 5, 2019

New sphingosine 1-phosphate receptor antagonists reported by Galapagos

Jan. 29, 2019

I-Mab Biopharma begins first-in-human study of TJ-003234

Jan. 28, 2019

Results from phase I/II study of rituximab biosimilar ABP-798 in rheumatoid arthritis

Jan. 25, 2019

Study more than doubles known osteoarthritis risk genes

Jan. 25, 2019

KZR-616, a dual immunoproteasome subunit inhibitor for autoimmune diseases

Jan. 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...